Alessia Tacito

892 total citations
20 papers, 608 citations indexed

About

Alessia Tacito is a scholar working on Endocrinology, Diabetes and Metabolism, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Alessia Tacito has authored 20 papers receiving a total of 608 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Endocrinology, Diabetes and Metabolism, 7 papers in Oncology and 6 papers in Pathology and Forensic Medicine. Recurrent topics in Alessia Tacito's work include Thyroid Cancer Diagnosis and Treatment (16 papers), Genetic factors in colorectal cancer (6 papers) and Cancer-related Molecular Pathways (5 papers). Alessia Tacito is often cited by papers focused on Thyroid Cancer Diagnosis and Treatment (16 papers), Genetic factors in colorectal cancer (6 papers) and Cancer-related Molecular Pathways (5 papers). Alessia Tacito collaborates with scholars based in Italy and United States. Alessia Tacito's co-authors include Rossella Elisei, Raffaele Ciampi, Cristina Romei, Valeria Bottici, Clara Ugolini, Fulvio Basolo, David Viola, Virginia Cappagli, Liborio Torregrossa and Teresa Ramone and has published in prestigious journals such as Archives of Biochemistry and Biophysics, Oncotarget and Journal of Medical Genetics.

In The Last Decade

Alessia Tacito

20 papers receiving 598 citations

Peers

Alessia Tacito
Alessia Tacito
Citations per year, relative to Alessia Tacito Alessia Tacito (= 1×) peers Rita Domingues

Countries citing papers authored by Alessia Tacito

Since Specialization
Citations

This map shows the geographic impact of Alessia Tacito's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alessia Tacito with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alessia Tacito more than expected).

Fields of papers citing papers by Alessia Tacito

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alessia Tacito. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alessia Tacito. The network helps show where Alessia Tacito may publish in the future.

Co-authorship network of co-authors of Alessia Tacito

This figure shows the co-authorship network connecting the top 25 collaborators of Alessia Tacito. A scholar is included among the top collaborators of Alessia Tacito based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alessia Tacito. Alessia Tacito is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Giani, Carlotta, Teresa Ramone, Cristina Romei, et al.. (2020). A New MEN2 Syndrome with Clinical Features of Both MEN2A and MEN2B Associated with a New RET Germline Deletion. Case Reports in Endocrinology. 2020(1). 4147097–4147097. 4 indexed citations
2.
Ciampi, Raffaele, Cristina Romei, Teresa Ramone, et al.. (2019). Genetic Landscape of Somatic Mutations in a Large Cohort of Sporadic Medullary Thyroid Carcinomas Studied by Next-Generation Targeted Sequencing. iScience. 20. 324–336. 133 indexed citations
3.
Elisei, Rossella, Valeria Bottici, Virginia Cappagli, et al.. (2019). Clinical utility of genetic diagnosis for sporadic and hereditary medullary thyroid carcinoma. Annales d Endocrinologie. 80(3). 187–190. 12 indexed citations
4.
Ramone, Teresa, Cristina Romei, Raffaele Ciampi, et al.. (2019). Differential expression of RET isoforms in normal thyroid tissues, papillary and medullary thyroid carcinomas. Endocrine. 65(3). 623–629. 3 indexed citations
5.
Valerio, Laura, Valeria Bottici, Antonio Matrone, et al.. (2019). Predictive factors of short and long-term vandetanib response in locally advanced or metastatic medullary thyroid cancer: a single center experience. Endocrine Abstracts. 1 indexed citations
6.
Elisei, Rossella, Alessia Tacito, Teresa Ramone, et al.. (2019). Twenty-Five Years Experience on RET Genetic Screening on Hereditary MTC: An Update on The Prevalence of Germline RET Mutations. Genes. 10(9). 698–698. 62 indexed citations
7.
Valerio, Laura, Valeria Bottici, Antonio Matrone, et al.. (2019). Medullary thyroid cancer treated with vandetanib: predictors of a longer and durable response. Endocrine Related Cancer. 27(2). 97–110. 29 indexed citations
8.
Romei, Cristina, Alessia Tacito, Eleonora Molinaro, et al.. (2018). Clinical, pathological and genetic features of anaplastic and poorly differentiated thyroid cancer: A single institute experience. Oncology Letters. 15(6). 9174–9182. 41 indexed citations
9.
Romei, Cristina, Raffaele Ciampi, Alessia Tacito, et al.. (2018). RET mutation heterogeneity in primary advanced medullary thyroid cancers and their metastases. Oncotarget. 9(11). 9875–9884. 37 indexed citations
10.
Ciampi, Raffaele, Cristina Romei, Letizia Pieruzzi, et al.. (2016). Classical point mutations of RET, BRAF and RAS oncogenes are not shared in papillary and medullary thyroid cancer occurring simultaneously in the same gland. Journal of Endocrinological Investigation. 40(1). 55–62. 22 indexed citations
11.
Romei, Cristina, Raffaele Ciampi, Alessia Tacito, et al.. (2016). Genetic heterogeneity of medullary thyroid carcinoma. Endocrine Abstracts. 1 indexed citations
12.
Romei, Cristina, Alessia Tacito, Valeria Bottici, et al.. (2016). New insights in the molecular signature of advanced medullary thyroid cancer: evidence of a bad outcome of cases with double RET mutations. Journal of Medical Genetics. 53(11). 729–734. 61 indexed citations
13.
Romei, Cristina, Alessia Tacito, Eleonora Molinaro, et al.. (2014). Twenty years of lesson learning: how does the RET genetic screening test impact the clinical management of medullary thyroid cancer?. Clinical Endocrinology. 82(6). 892–899. 36 indexed citations
14.
Romei, Cristina, Alessia Tacito, A Vivaldi, et al.. (2013). GENETIC SCREENING OF RET CAN IDENTIFY NEW MUTATIONS EVEN AFTER 20 YEARS. CINECA IRIS Institutial research information system (University of Pisa). 1 indexed citations
15.
Vivaldi, A, Raffaele Ciampi, Alessia Tacito, et al.. (2012). Celecoxib, a cyclooxygenase-2 inhibitor, potentiates the chemotherapic effect of vinorelbine in the medullary thyroid cancer TT cell line. Molecular and Cellular Endocrinology. 355(1). 41–48. 14 indexed citations
16.
Ugolini, Clara, Barbara Cosci, A Vivaldi, et al.. (2012). LOW PREVALENCE OF THE SOMATIC M918T RET MUTATION IN MICRO-MEDULLARY THYROID CANCER. Thyroid. 1379803369–1379803369. 5 indexed citations
17.
Romei, Cristina, Clara Ugolini, Barbara Cosci, et al.. (2012). Low Prevalence of the Somatic M918T RET Mutation in Micro-Medullary Thyroid Cancer. Thyroid. 22(5). 476–481. 52 indexed citations
18.
Vivaldi, A, Cristina Romei, Federica Gemignani, et al.. (2011). In silico and in vitro analysis of rare germline allelic variants of RET oncogene associated with medullary thyroid cancer. Endocrine Related Cancer. 18(5). 603–612. 49 indexed citations
19.
Ciampi, Raffaele, Cristina Romei, Barbara Cosci, et al.. (2011). Chromosome 10 and RET gene copy number alterations in hereditary and sporadic Medullary Thyroid Carcinoma. Molecular and Cellular Endocrinology. 348(1). 176–182. 20 indexed citations
20.
Angeli, Valéria Weiss, Alessia Tacito, Aldo Paolicchi, et al.. (2008). A kinetic study of gamma-glutamyltransferase (GGT)-mediated S-nitrosoglutathione catabolism. Archives of Biochemistry and Biophysics. 481(2). 191–196. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026